2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.

@article{Hanu20012arachidonylGE,
  title={2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.},
  author={Lum{\'i}r Ondřej Hanu{\vs} and Saleh Abu-Lafi and Ester Fride and Aviva Breuer and Zvi Vogel and Deborah E. Shalev and Irina Kustanovich and Raphael Mechoulam},
  journal={Proceedings of the National Academy of Sciences of the United States of America},
  year={2001},
  volume={98 7},
  pages={3662-5}
}
Two types of endogenous cannabinoid-receptor agonists have been identified thus far. They are the ethanolamides of polyunsaturated fatty acids--arachidonoyl ethanolamide (anandamide) is the best known compound in the amide series--and 2-arachidonoyl glycerol, the only known endocannabinoid in the ester series. We report now an example of a third, ether-type endocannabinoid, 2-arachidonyl glyceryl ether (noladin ether), isolated from porcine brain. The structure of noladin ether was determined… CONTINUE READING
Highly Influential
This paper has highly influenced 10 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 230 extracted citations

Endocannabinoids: synthesis and degradation.

Reviews of physiology, biochemistry and pharmacology • 2008
View 4 Excerpts
Highly Influenced

References

Publications referenced by this paper.

Platelet Activating Factor and Human Disease (Blackwell Scientific, Oxford)

P. J. Barnes, C. P. Page, P. M. Henson, eds
1989

Similar Papers

Loading similar papers…